Detalhe da pesquisa
1.
In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control.
Endocr J
; 68(5): 599-603, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33408313